Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.79B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$576M |
| 3 |
Microsoft
MSFT
|
+$546M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$436M |
| 5 |
JPMorgan Chase
JPM
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.48B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$765M |
| 4 |
Apple
AAPL
|
+$656M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$526M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.23% |
| 2 | Technology | 2.7% |
| 3 | Consumer Discretionary | 1.66% |
| 4 | Financials | 1.18% |
| 5 | Communication Services | 1.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TOKE
11001
DELISTED
Cambria Cannabis ETF
TOKE
| $86.8K | ﹤0.01% |
15,038
-6,301
| -30% | -$37.7K |
|
11002
CALL
CareDx
CDNA
$2.71B
| $86.7K | ﹤0.01% |
10,200
-14,400
| -59% | -$120K |
|
|
SOLO
11003
PUT
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
| $86.4K | ﹤0.01% |
139,400
+26,400
| +23% | +$15.2K |
|
11004
CALL
FTC Solar
FTCI
$40.1M
| $86.3K | ﹤0.01% |
2,680
-710
| -21% | -$19.5K |
|
|
GRTS
11005
CALL
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $86K | ﹤0.01% |
+44,100
| New | +$103K |
|
11006
CALL
Redwire
RDW
$2.82B
| $85.9K | ﹤0.01% |
33,700
-59,500
| -64% | -$162K |
|
11007
Travelzoo
TZOO
$67.9M
| $85.9K | ﹤0.01% |
+10,887
| New | +$87.6K |
|
11008
Destination XL Group
DXLG
$34.3M
| $85.8K | ﹤0.01% |
17,507
-50,625
| -74% | -$238K |
|
|
TURN
11009
DELISTED
180 Degree Capital
TURN
| $85.6K | ﹤0.01% |
18,991
-20,742
| -52% | -$97K |
|
11010
CALL
Jasper Therapeutics
JSPR
$23.3M
| $85.6K | ﹤0.01% |
6,250
-950
| -13% | -$14.1K |
|
11011
CALL
Adaptive Biotechnologies
ADPT
$4.22B
| $85.2K | ﹤0.01% |
12,700
-400
| -3% | -$2.97K |
|
11012
Oric Pharmaceuticals
ORIC
$1.42B
| $85.2K | ﹤0.01% |
10,976
-227,462
| -95% | -$1.29M |
|
11013
PUT
GoPro
GPRO
$112M
| $84.9K | ﹤0.01% |
20,500
-5,300
| -21% | -$22.7K |
|
11014
CALL
NextCure
NXTC
$27.6M
| $84.8K | ﹤0.01% |
3,925
+2,842
| +262% | +$56K |
|
11015
Lloyds Banking Group
LYG
$85.7B
| $84.7K | ﹤0.01% |
38,512
-198,646
| -84% | -$456K |
|
11016
Precigen
PGEN
$2.57B
| $84.7K | ﹤0.01% |
73,653
-59,186
| -45% | -$69.9K |
|
|
VRAY
11017
DELISTED
ViewRay, Inc.
VRAY
| $84.4K | ﹤0.01% |
239,739
-1,691,385
| -88% | -$1.75M |
|
11018
CALL
RPC Inc
RES
$1.42B
| $84.4K | ﹤0.01% |
11,800
-44,800
| -79% | -$328K |
|
11019
Acacia Research
ACTG
$438M
| $84.1K | ﹤0.01% |
20,207
-123,258
| -86% | -$497K |
|
11020
CALL
KNOT Offshore Partners
KNOP
$366M
| $84K | ﹤0.01% |
17,000
-43,200
| -72% | -$215K |
|
11021
CALL
Immunome
IMNM
$3.28B
| $83.8K | ﹤0.01% |
+10,600
| New | +$58K |
|
11022
PUT
Holley
HLLY
$360M
| $83.8K | ﹤0.01% |
+20,500
| New | +$61.1K |
|
11023
CALL
Anixa Biosciences
ANIX
$122M
| $83.8K | ﹤0.01% |
+26,200
| New | +$101K |
|
11024
CALL
Energy Vault
NRGV
$682M
| $83.8K | ﹤0.01% |
30,700
+14,000
| +84% | +$29.5K |
|
|
CTG
11025
DELISTED
Computer Task Group, Inc.
CTG
| $83.4K | ﹤0.01% |
+10,953
| New | +$76K |
|
Similar funds
Jeff Yass's Q2 2023 Portfolio in Review
As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2023 filing shows 1,371 new, 4,862 increased, 5,559 reduced and 1,866 closed positions. Its largest new stake was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M. The largest sale was Invesco QQQ Trust, an estimated $2.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
- Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
- Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
- Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
- Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
- Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
- Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.
Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.